27.04.2013 Views

MORRIS LASTER, MD - Kenes

MORRIS LASTER, MD - Kenes

MORRIS LASTER, MD - Kenes

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

<strong>MORRIS</strong> <strong>LASTER</strong>, <strong>MD</strong><br />

Page 3<br />

BOARD CERTIFICATION<br />

1991 Diplomate National Board of Medical Examiners (USA)<br />

Certificate Number 387204<br />

MEDICAL LICENSE<br />

1993 Israeli Medical License Number 26753<br />

1990 Ohio State Medical License Number 062626<br />

PATENTS<br />

-An Implantable Device for the Treatment of ESRD and Use Thereof (In submission)<br />

-Conjugates Capable of Crossing the Blood-Brain Barrier (US Provisional No 60/674,302)<br />

-Bone Marrow as a Site For Transplantation (Granted US 6,463,933, Australia)<br />

-Compounds for the Modulation of Kinase Associated Signal Transduction (US Patent<br />

Application Ser. No. 10/205302)<br />

-Methods Using Glycosaminoglycans For The Treatment of Nephropathy (US Patent<br />

Application Ser. No. 11/124,531)<br />

-Use of Sulodexide for the Treatment of IBD (US Patent Application Ser. No.10/147681).<br />

ASSOCIATIONS<br />

BIO Biotechnology Organization<br />

Israel Biotechnology Organization<br />

American Medical Association<br />

Israeli Medical Association<br />

American Association for the Advancement of Science<br />

American Society for Gene Therapy<br />

PUBLICATIONS<br />

1) Anis Y, Leshem O, Reuveni H, Wexler I, Ben Sasson R, Yahalom B, Laster<br />

M, Raz I, Ben Sasson S, Shafrir E, Ziv E. Antidiabetic Effect of Novel<br />

Modulating Peptides of G-Protein Coupled Kinase in Experimental Models<br />

of Diabetes. Diabetologia. 47:1232-1244 (2004)<br />

2) Niv M, Rubin H, Cohen J, Licht T, Peretzman-Shemer A, Cnaan E,<br />

Tartakovski A, Stein I, Albeck S, Tsirulnikov L, Goldenberg-Furmanov M,<br />

Weinstein I, Tobi D, Seger R, Laster M, Ben-Sasson SA, Reuveni H. A<br />

Novel Technology for Sequence Based kinase inhibitors for therapeutic and<br />

target identification applications. J Biol Chem. 279(2):1242-55 (2004)<br />

3) Schachter PP, Ayesh S, Schneider T, Laster M, Czerniak A, Hochberg A.<br />

Expression of kinase genes in primary hyperparathyroidism: Adenoma versus<br />

hyperplastic parathyroid tissue. Surgery 132(6):1094-9 (2002)<br />

4) Ayesh S, Matouk I, Schneider T, Ohana P, Laster M, Al-Sharef W, deGroot<br />

N, Hochberg A. The Possible Physiological Role of H19 RNA. Molecular<br />

Carcinogenesis 35(2):63-74 (2002)

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!